We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+0.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4B
AUM Growth
+$261M
(+7%)
Cap. Flow
+$281M
Cap. Flow
% of AUM
7.02%
Top 10 Holdings %
Top 10 Hldgs %
19.74%
Holding
679
New
127
Increased
246
Reduced
223
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$104M |
| 2 |
Apple
AAPL
|
+$60.7M |
| 3 |
Amazon
AMZN
|
+$47.5M |
| 4 |
American Express
AXP
|
+$28.7M |
| 5 |
Travelers Companies
TRV
|
+$27.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Solar
FSLR
|
+$28.1M |
| 2 |
Johnson & Johnson
JNJ
|
+$28.1M |
| 3 |
Clorox
CLX
|
+$26.2M |
| 4 |
TJX Companies
TJX
|
+$24.8M |
| 5 |
McKesson
MCK
|
+$23.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.39% |
| 2 | Financials | 11.87% |
| 3 | Technology | 10.68% |
| 4 | Communication Services | 10.67% |
| 5 | Consumer Discretionary | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
226
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.71M | 0.09% |
134,000
-2,200
| -2% | -$73.3K |
|
|
NBL
227
DELISTED
Noble Energy, Inc.
NBL
| $3.67M | 0.09% |
117,328
+8,295
| +8% | +$254K |
|
228
Bank of America
BAC
$435B
| $3.63M | 0.09% |
+269,571
| New | +$3.64M |
|
229
Ford
F
$57.3B
| $3.62M | 0.09% |
269,399
+10,799
| +4% | +$136K |
|
230
TechnipFMC
FTI
$30.6B
| $3.59M | 0.09% |
+177,464
| New | +$3.35M |
|
231
Marriott International
MAR
$98.7B
| $3.59M | 0.09% |
50,743
-69,605
| -58% | -$4.55M |
|
232
Kinder Morgan
KMI
$73.1B
| $3.56M | 0.09% |
200,580
-100,257
| -33% | -$1.64M |
|
233
Phillips 66
PSX
$82.9B
| $3.55M | 0.09% |
41,197
-54,841
| -57% | -$4.46M |
|
234
Revvity
RVTY
$12.3B
| $3.54M | 0.09% |
+71,971
| New | +$3.44M |
|
235
Synchrony
SYF
$23.7B
| $3.49M | 0.09% |
122,506
-6,806
| -5% | -$189K |
|
236
BCE
BCE
$19.9B
| $3.47M | 0.09% |
76,175
-4,520
| -6% | -$189K |
|
237
Range Resources
RRC
$9.11B
| $3.42M | 0.09% |
106,298
-62,007
| -37% | -$1.72M |
|
238
Humana
HUM
$46.7B
| $3.4M | 0.09% |
18,708
+2,158
| +13% | +$374K |
|
239
International Paper
IP
$22.3B
| $3.38M | 0.08% |
87,456
-88,323
| -50% | -$3.08M |
|
240
Automatic Data Processing
ADP
$100B
| $3.37M | 0.08% |
+37,713
| New | +$3.16M |
|
241
DTE Energy
DTE
$31.1B
| $3.37M | 0.08% |
43,850
-32,594
| -43% | -$2.35M |
|
242
Ovintiv
OVV
$17.5B
| $3.36M | 0.08% |
110,338
+27,721
| +34% | +$638K |
|
243
United Parcel Service
UPS
$97.6B
| $3.31M | 0.08% |
31,600
+6,905
| +28% | +$671K |
|
|
CTXS
244
DELISTED
Citrix Systems Inc
CTXS
| $3.28M | 0.08% |
52,632
-252,713
| -83% | -$14.3M |
|
245
Becton Dickinson
BDX
$43.1B
| $3.27M | 0.08% |
+22,213
| New | +$3.15M |
|
246
Mattel
MAT
$4.17B
| $3.25M | 0.08% |
97,317
+89,528
| +1,149% | +$2.72M |
|
247
Teva Pharmaceuticals
TEVA
$35.9B
| $3.22M | 0.08% |
60,553
+7,560
| +14% | +$444K |
|
248
Colgate-Palmolive
CL
$72.6B
| $3.19M | 0.08% |
45,402
-10,301
| -18% | -$685K |
|
249
Puma Biotechnology
PBYI
$406M
| $3.18M | 0.08% |
109,000
+24,700
| +29% | +$1.12M |
|
250
US Bancorp
USB
$99.6B
| $3.17M | 0.08% |
78,619
-1,302
| -2% | -$52K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q1 2016 Portfolio in Review
As of Q1 2016, Candriam SCA held 679 positions worth $4B, up 7% from $3.74B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Candriam SCA deployed $281M of net new capital in Q1 2016, opening 127 new positions and adding to 246 existing holdings. Its largest new stake was Amgen: 700,333 shares worth $104M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 29% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was First Solar, an estimated $28.1M trimmed.
- Candriam SCA's largest Q1 2016 buy was Amgen: 700,333 shares worth $104M.
- Candriam SCA added most to Mead Johnson Nutrition Company in Q1 2016, an estimated $22.2M increase.
- Candriam SCA's biggest Q1 2016 reduction was First Solar, cutting an estimated $28.1M.
- Candriam SCA fully exited Avangrid, Inc. in Q1 2016, selling an estimated $9.6M.
- Candriam SCA's ten largest holdings make up 20% of its $4B portfolio in Q1 2016.
- Candriam SCA opened 127 new positions and closed 43 in Q1 2016.
- Candriam SCA's portfolio value rose 7% quarter-over-quarter to $4B.
Based on Candriam SCA's 13F filing for Q1 2016, filed 27 Apr 2016.